More Immutep Ltd news
Immutep LtdASX: IMM

S&P DJI Announces March 2021 Quarterly Rebalance

Mar 12, 2021 at 6:23 AM EST · Issued by Immutep Ltd

Filed with ASX · Mar 12, 2021 at 6:23 AM EST · 9 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-march-2021-quarterly-rebalance-70

Immutep Ltd on 6ix

Earlier from Immutep

  • Immutep secures second US patent grant for eftilagimod alphaMar 9, 2021
  • Phase II study for eftilagimod alpha in COVID-19 advancesJan 26, 2021
  • Ulcerative Colitis Phase II Study of GSK2831781 DiscontinuedJan 21, 2021
  • Recruitment of head & neck cancer patients completed for ph2Jan 6, 2021
  • Immutep granted US patent for eftilagimod alpha with a PD-1Dec 29, 2020

Later from Immutep

  • Immutep collaborates with MSD for phase 2b head & neck trialMar 15, 2021
  • Immutep announces European Patent Grant for LAG525Apr 6, 2021
  • Immutep achieves Fast Track designation for Efti from US FDAApr 7, 2021
  • Immutep receives A$1,155,055 R&D Tax IncentiveApr 16, 2021
  • TACTI-002 & INSIGHT-004 data to be presented at ASCOApr 28, 2021
All Immutep news releases↗

Follow Immutep into a list and get an email when it puts out news.

Follow Immutep
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer